FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2330279868> ?p ?o ?g. }

• W2330279868 endingPage "1130" @default.
• W2330279868 startingPage "1121" @default.
• W2330279868 abstract "Objectives: In a multicenter, placebo-controlled, randomized, double-blind trial, we showed that acquired infections in intubated patients were reduced by the combination of topical polymyxin plus tobramycin and nasal mupirocin plus chlorhexidine body wash. Because intubated patients are particularly at risk for acquired infections, we reassessed the impact of this protocol as a routine procedure to control acquired infections in the ICU. Design: Nonrandomized study comparing acquired infections in ICU patients during two 1-year periods: the last year before (group A, n = 925) and the first year after the implementation of the protocol (group B, n = 1,022). Acquired infections were prospectively recorded. Setting: Polyvalent medical ICU at a university-affiliated hospital. Patients: All patients admitted to the ICU. Interventions: Administration of polymyxin/tobramycin/amphotericin B in the oropharynx and the gastric tube plus a mupirocin/chlorhexidine regimen in intubated patients and standard care in the other patients. Measurements and Main Results: The comparison of acquired infection rates between groups was adjusted for differences at baseline. Infection rates were lower in group B compared with group A (5.3% vs 11.0%; p < 0.001), as were the incidence rates of total acquired infections (9.4 vs 23.6 per 1,000 patient-days; p < 0.001), intubation-related pneumonia (5.1 vs 17.1 per 1,000 ventilator-days; p < 0.001), and catheter-related bloodstream infections (1.0 vs 3.5 per 1,000 catheter-days; p = 0.03). There were fewer acquired infections caused by ceftazidime-resistant Enterobacteriaceae (0.8‰ vs 3.6‰; p < 0.001), ciprofloxacin-resistant Enterobacteriaceae (0.8‰ vs 2.5‰; p = 0.02), ciprofloxacin-resistant Pseudomonas aeruginosa (0.5‰ vs 1.6‰; p = 0.05), and colistin-resistant Gram-negative bacilli (0.7‰ vs 1.9‰; p = 0.04). Fewer patients got acquired infections due to multidrug-resistant aerobic Gram-negative bacilli (p = 0.008). Conclusions: In intubated patients, the use of topical polymyxin/tobramycin/amphotericin B plus mupirocin/chlorhexidine was associated with the reduction of all-cause ICU-acquired infections. Long-term emergence of multidrug-resistant organisms deserves further investigation." @default.
• W2330279868 created "2016-06-24" @default.
• W2330279868 creator A5000600966 @default.
• W2330279868 creator A5030945695 @default.
• W2330279868 creator A5036752849 @default.
• W2330279868 creator A5046832947 @default.
• W2330279868 creator A5051961197 @default.
• W2330279868 creator A5063169655 @default.
• W2330279868 creator A5064178366 @default.
• W2330279868 creator A5066190123 @default.
• W2330279868 creator A5067523427 @default.
• W2330279868 creator A5079518592 @default.
• W2330279868 creator A5081103160 @default.
• W2330279868 date "2014-05-01" @default.
• W2330279868 modified "2023-10-10" @default.
• W2330279868 title "Short-Term Decline in All-Cause Acquired Infections With the Routine Use of a Decontamination Regimen Combining Topical Polymyxin, Tobramycin, and Amphotericin B With Mupirocin and Chlorhexidine in the ICU" @default.
• W2330279868 cites W1964823995 @default.
• W2330279868 cites W1965085996 @default.
• W2330279868 cites W1969383727 @default.
• W2330279868 cites W1979613180 @default.
• W2330279868 cites W2013556542 @default.
• W2330279868 cites W2031804971 @default.
• W2330279868 cites W2037887534 @default.
• W2330279868 cites W2039981579 @default.
• W2330279868 cites W2041215841 @default.
• W2330279868 cites W2055306795 @default.
• W2330279868 cites W2065088137 @default.
• W2330279868 cites W2070513607 @default.
• W2330279868 cites W2073060575 @default.
• W2330279868 cites W2074610618 @default.
• W2330279868 cites W2078833739 @default.
• W2330279868 cites W2091004522 @default.
• W2330279868 cites W2096070973 @default.
• W2330279868 cites W2103167863 @default.
• W2330279868 cites W2103315560 @default.
• W2330279868 cites W2106524826 @default.
• W2330279868 cites W2116071191 @default.
• W2330279868 cites W2123797220 @default.
• W2330279868 cites W2128799206 @default.
• W2330279868 cites W2135801231 @default.
• W2330279868 cites W2137245509 @default.
• W2330279868 cites W2145922229 @default.
• W2330279868 cites W2150604375 @default.
• W2330279868 cites W2157715904 @default.
• W2330279868 cites W2160977481 @default.
• W2330279868 cites W2170493477 @default.
• W2330279868 cites W2216742732 @default.
• W2330279868 cites W2218892404 @default.
• W2330279868 cites W2325712546 @default.
• W2330279868 doi "https://doi.org/10.1097/ccm.0000000000000140" @default.
• W2330279868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24365857" @default.
• W2330279868 hasPublicationYear "2014" @default.
• W2330279868 type Work @default.
• W2330279868 sameAs 2330279868 @default.
• W2330279868 citedByCount "20" @default.
• W2330279868 countsByYear W23302798682015 @default.
• W2330279868 countsByYear W23302798682016 @default.
• W2330279868 countsByYear W23302798682017 @default.
• W2330279868 countsByYear W23302798682018 @default.
• W2330279868 countsByYear W23302798682020 @default.
• W2330279868 countsByYear W23302798682021 @default.
• W2330279868 countsByYear W23302798682022 @default.
• W2330279868 countsByYear W23302798682023 @default.
• W2330279868 crossrefType "journal-article" @default.
• W2330279868 hasAuthorship W2330279868A5000600966 @default.
• W2330279868 hasAuthorship W2330279868A5030945695 @default.
• W2330279868 hasAuthorship W2330279868A5036752849 @default.
• W2330279868 hasAuthorship W2330279868A5046832947 @default.
• W2330279868 hasAuthorship W2330279868A5051961197 @default.
• W2330279868 hasAuthorship W2330279868A5063169655 @default.
• W2330279868 hasAuthorship W2330279868A5064178366 @default.
• W2330279868 hasAuthorship W2330279868A5066190123 @default.
• W2330279868 hasAuthorship W2330279868A5067523427 @default.
• W2330279868 hasAuthorship W2330279868A5079518592 @default.
• W2330279868 hasAuthorship W2330279868A5081103160 @default.
• W2330279868 hasConcept C126322002 @default.
• W2330279868 hasConcept C141071460 @default.
• W2330279868 hasConcept C2775832221 @default.
• W2330279868 hasConcept C2776315533 @default.
• W2330279868 hasConcept C2776376669 @default.
• W2330279868 hasConcept C2777052132 @default.
• W2330279868 hasConcept C2777637488 @default.
• W2330279868 hasConcept C2778246068 @default.
• W2330279868 hasConcept C2778974779 @default.
• W2330279868 hasConcept C2779489039 @default.
• W2330279868 hasConcept C2780026444 @default.
• W2330279868 hasConcept C2780558435 @default.
• W2330279868 hasConcept C2780908437 @default.
• W2330279868 hasConcept C2781413609 @default.
• W2330279868 hasConcept C42219234 @default.
• W2330279868 hasConcept C501593827 @default.
• W2330279868 hasConcept C523546767 @default.
• W2330279868 hasConcept C54355233 @default.
• W2330279868 hasConcept C71924100 @default.
• W2330279868 hasConcept C86803240 @default.
• W2330279868 hasConcept C89423630 @default.
• W2330279868 hasConceptScore W2330279868C126322002 @default.
• W2330279868 hasConceptScore W2330279868C141071460 @default.

• next